Thus, these findings show that leukocyte IRS1 gene expression attenuates as insulin resistance decreases from pregnancy to postpartum in women with GDM, suggesting that leukocyte IRS1 transcript level could be related to whole-body insulin resistance status in GDM women at the time of GDM diagnosis and at 1-year follow-up. This evidence concerns the gene IRS1 and gestational diabetes.